Intensity Therapeutics Competitors and Similar CompaniesClear all
OncoTherapy Science's competitors and similar companies include Bexion Pharmaceuticals, Acrivon and Numab.
 OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. |  Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. |  Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | ||
Founding Date | Founding Date 2001 | Founding Date 2006 | Founding Date 2018 | Founding Date 2011 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Kawasaki, JP HQ | Locations Covington, US HQ | Locations Watertown, US HQ Lund, SE | Locations Wädenswil, CH HQ |
Employees | Employees 54 | Employees 274% increase | Employees 415% increase | Employees 681% decrease |
Valuation ($) | Valuation ($) 56.9 m | Valuation ($) N/A | Valuation ($) 256.1 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income (¥910.6m) (FY, 2026) | Net income N/A | Net income ($77.9m) (FY, 2025) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 16.6m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 110m (about 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 16.6m | Total funding raised N/A | Total funding raised $ 132.3m |
For sources of this data, please see the company profile
View Company Profiles
Bexion Pharmaceuticals
HQ
Covington, US
Employees
27↑ 4% increase
Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
View companyAcrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company